Search Results - "Pomie, Celine"
-
1
Defective NOD2 peptidoglycan sensing promotes diet‐induced inflammation, dysbiosis, and insulin resistance
Published in EMBO molecular medicine (01-03-2015)“…Pattern recognition receptors link metabolite and bacteria‐derived inflammation to insulin resistance during obesity. We demonstrate that NOD2 detection of…”
Get full text
Journal Article -
2
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy
Published in Cancer research communications (01-11-2022)“…The receptor tyrosine kinase VEGFR-3 plays a crucial role in cancer-induced angiogenesis and lymphangiogenesis, promoting tumor development and metastasis…”
Get full text
Journal Article -
3
Metagenome and metabolism: the tissue microbiota hypothesis
Published in Diabetes, obesity & metabolism (01-09-2013)“…Over the last decade, the research community has revealed the role of a new organ: the intestinal microbiota. It is considered as a symbiont that is part of…”
Get full text
Journal Article -
4
CX3CR1 regulates gut microbiota and metabolism. A risk factor of type 2 diabetes
Published in Acta diabetologica (01-08-2021)“…Objective The intestinal microbiota to immune system crosstalk is a major regulator of metabolism and hence metabolic diseases. An impairment of the chemokine…”
Get full text
Journal Article -
5
Corrupted adipose tissue endogenous myelopoiesis initiates diet-induced metabolic disease
Published in eLife (28-06-2017)“…Activation and increased numbers of inflammatory macrophages, in adipose tissue (AT) are deleterious in metabolic diseases. Up to now, AT macrophages (ATM)…”
Get full text
Journal Article -
6
Mouse and human CD8+ CD28low regulatory T lymphocytes differentiate in the thymus
Published in Immunology (01-06-2016)“…Summary Regulatory T (Treg) lymphocytes play a central role in the control of immune responses and so maintain immune tolerance and homeostasis. In mice,…”
Get full text
Journal Article -
7
Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response
Published in Gut (01-05-2017)“…To identify a causal mechanism responsible for the enhancement of insulin resistance and hyperglycaemia following periodontitis in mice fed a fat-enriched…”
Get more information
Journal Article -
8
Immuno-microbiota cross and talk: The new paradigm of metabolic diseases
Published in Seminars in immunology (01-02-2012)“…Highlights ► A new paradigm is needed for the treatment of metabolic diseases. ► Bacterial fragments such as lipopolysaccharides initiate high fat diet induced…”
Get full text
Journal Article -
9
The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease
Published in Cell metabolism (07-07-2015)“…A high-fat diet (HFD) induces metabolic disease and low-grade metabolic inflammation in response to changes in the intestinal microbiota through as-yet-unknown…”
Get full text
Journal Article -
10
Abstract 3768: Identification of a novel non-brain penetrant A2AR inhibitor and proof-of-concept of CD73 and A2AR/CD73 small-molecule inhibitors for cancer immunotherapy
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Adenosine, generated by CD73 is a key driver of immunosuppression in the hypoxic tumour microenvironment (TME). In immune-inflamed tumours, with CD8+…”
Get full text
Journal Article -
11
Abstract 2753: Translation to the clinic of EVT801: A novel immune-oncology agent for addressing innate-driven immunosuppression into the tumor microenvironment and expanding patient population responding to immune checkpoint therapies
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Amongst resistance mechanisms of immune checkpoint therapies (ICTs), expansion and recruitment of immunosuppressive innate cells and in particular…”
Get full text
Journal Article -
12
Abstract 519: EVOEXS21546 is a novel non-brain penetrant A2AR inhibitor for cancer immunotherapy with accelerated drug development
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Evotec and Exscientia are collaborating to develop an innovative drug discovery platform for accelerating small molecule development in…”
Get full text
Journal Article -
13
Abstract 507: Identification of CD73 and A2AR/CD73 small molecule inhibitors for cancer immunotherapy as single agents or in combination with Immune-checkpoint therapies
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Adenosine generated by CD73 is a key driver of immunosuppression in the hypoxic tumour microenvironment (TME) and particularly involved in angiogenic…”
Get full text
Journal Article -
14
Gut Microbiota Cool-Down Burning Fat! The Immune Hypothesis
Published in Trends in endocrinology and metabolism (01-02-2016)“…Obesity is characterized by gut microbiota dysbiosis and reduced thermogenic activity of brown adipose tissue. A recent study reveals that gut microbiota…”
Get full text
Journal Article -
15
Abstract 3203: Cutting edge biomarkers strategy to provide early insights into activity of EVT-801, a novel selective VEGFR-3 inhibitor that targets tumor angiogenesis during the FIH clinical trial
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Introduction: EVT801 is a highly selective small molecule inhibitor of VEGFR3 and acts by inhibiting lymphangiogenesis and tumor angiogenesis in and…”
Get full text
Journal Article -
16
Changes in Lipoprotein Kinetics Associated With Type 2 Diabetes Affect the Distribution of Lipopolysaccharides Among Lipoproteins
Published in The journal of clinical endocrinology and metabolism (01-07-2014)“…Context: Lipopolysaccharides (LPSs) are inflammatory components of the outer membrane of Gram-negative bacteria and, in plasma, are mostly associated with…”
Get full text
Journal Article -
17
Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia
Published in Molecular metabolism (Germany) (01-06-2016)“…Abstract Objective To demonstrate that glycemia and insulin resistance are controlled by a mechanism involving the adaptive immune system and gut microbiota…”
Get full text
Journal Article -
18
Mouse and human CD8(+) CD28(low) regulatory T lymphocytes differentiate in the thymus
Published in Immunology (01-06-2016)“…Regulatory T (Treg) lymphocytes play a central role in the control of immune responses and so maintain immune tolerance and homeostasis. In mice, expression of…”
Get full text
Journal Article -
19
Defective NOD 2 peptidoglycan sensing promotes diet‐induced inflammation, dysbiosis, and insulin resistance
Published in EMBO molecular medicine (01-03-2015)“…Abstract Pattern recognition receptors link metabolite and bacteria‐derived inflammation to insulin resistance during obesity. We demonstrate that NOD 2…”
Get full text
Journal Article -
20
CD8 +CD28 − Regulatory T Lymphocytes Prevent Experimental Inflammatory Bowel Disease in Mice
Published in Gastroenterology (New York, N.Y. 1943) (01-12-2006)“…Background & Aims: Immune responses to innocuous intestinal antigens appear tightly controlled by regulatory T lymphocytes. While CD4 + T lymphocytes have…”
Get full text
Journal Article